Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
58 participants
INTERVENTIONAL
2024-02-24
2024-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
• To assess the therapeutic benefit of vitamin D supplement in acne vulgaris treatment, following a 2-month treatment regimen that includes vitamin D supplementation compared to conventional (systemic azithromycin and topical retinoid) treatment alone.
Participants will receive vitamin D supplements in addition to capsule Azithromycin and topical retinoid.
Researchers will compare groups to determine efficacy of Vitamin D supplements in the treatment of Acne vulgaris.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vitamin A and Azithromycin for Acne Vulgaris
NCT03090048
The Efficacy and Safety of Topical Vitamin D and Supplementation In Acne Vulgaris The Study of VDR, IL-1β, IL-6, IL-10 and IL-17 Expression
NCT05758259
Role of Vitamin D and Its Topical Analogues in Pathogenesis and Treatment of Acne Vulgaris
NCT03866447
Anti-microbial Role of Non-antibiotic Agents Against Cutibacterium Acnes in Patients With Acne Vulgaris
NCT06179056
Comparing Efficacy of Azithromycin and Probiotics for Treatment of Acne Vulgaris
NCT05629468
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vitamin D
D Max Drops
Vitamin D
Azithromycin 250 milligram Oral Capsule
Anti Biotic
Adapalene
Retinoid
Placebo
Azithromycin 250 milligram Oral Capsule
Anti Biotic
Adapalene
Retinoid
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
D Max Drops
Vitamin D
Azithromycin 250 milligram Oral Capsule
Anti Biotic
Adapalene
Retinoid
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Those with obesity
* Individuals employing vitamin supplementation
* Those under the influence of topical or systemic steroids and acne treatment in the last 2 months.
13 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
HITEC-Institute of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Aqsa Naheed
Professor, MBBS, FCPS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hitec-Ims
Islamabad, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Vit-D
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.